Healthcare practice strategies for integrating personalized medicine:Management of COVID-19

作     者：Wen-Yi Liu Ching-Wen Chien Tao-Hsin Tung 

作者机构：Department of Health Policy and ManagementBloomberg School of Public HealthJohns Hopkins UniversityMD 21205United StatesShanghai Bluecross Medical Science InstituteShanghai 201100Shanghai ProvinceChina Institute for Hospital ManagementTsing Hua UniversityShenzhen CampusShenzhen 518055Guangdong ProvinceChina Evidence-based Medicine CenterTaizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical UniversityLinhai 317000Zhejiang ProvinceChina 

出 版 物：《World Journal of Clinical Cases》 (世界临床病例杂志)

年 卷 期：2021年第9卷第29期

页      面：8647-8657页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Healthcare Personalized medicine COVID-19 SARS-CoV-2 

摘      要：Personalized medicine is the tailor-made clinical treatment to the individual characteristics of each *** may be considered an extension of traditional approaches to knowing and treating *** medicine has the potential to change the way of identification and management of health *** disease 2019(COVID-19)is an infectious disease that primarily affects the patients’*** first case of pneumonia of unknown cause was reported in Wuhan,China on December 31,*** thus,we are quickly approaching the era of personalized *** review discusses the practices currently used in the management of COVID-19 and how they relate to person-alized medicine.